Co-Discovery on the Enveda Platform
Partner with us to bolster your early-stage pipeline. Gain access to a one-of-a-kind library of scaffolds to power your toughest discovery campaigns, leverage your own library against our target candidates, or take advantage of our validated preclinical candidates.
Phenotypic discoveries in disease-relevant assays are used to discover both novel clinical candidates and disease targets.
We explore phenotypic endpoints in cellular assays that have demonstrated high predictive value for specific diseases. This allows our scientists to begin research projects right in the middle of the drug discovery process, and simultaneously
(a) move forward in optimization work to identify novel clinical candidates and
(b) use our technologies to explain the molecular mechanisms and novel targets underlying the disease processes.
Using our end-to-end discovery capabilities, we are actively developing multiple leads towards IND-enabling studies and validating target candidates discovered through our platform. Get in touch to learn more about our pipeline of leads and targets.